ARCA BIOPHARMA INC - COM (ABIO)

CUSIP: 00211Y506

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / COM
Total 13F shares
12,920,004
Share change
+5,721,173
Total reported value
$49,421,425
Put/Call ratio
13%
Price per share
$3.83
Number of holders
30
Value change
+$26,259,435
Number of buys
18
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 00211Y506?
CUSIP 00211Y506 identifies ABIO - ARCA BIOPHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ARCA BIOPHARMA INC - COM (ABIO) as of Q2 2024

As of 30 Jun 2024, ARCA BIOPHARMA INC - COM (ABIO) was held by 30 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,920,004 shares. The largest 10 holders included Cable Car Capital LLC, RTW INVESTMENTS, LP, JANUS HENDERSON GROUP PLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Avidity Partners Management LP, VR Adviser, LLC, COWEN AND COMPANY, LLC, MORGAN STANLEY, VANGUARD GROUP INC, and COMMODORE CAPITAL LP. This page lists 30 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.